Summary of provincial drug plan restrictions, criteria for reimbursement, and the lag time from Common Drug Review approval to provincial decision in Canadian provinces.
dataset
posted on 2014-09-09, 02:48 authored by Shiona K. Glass-Kaastra, Rita Finley, Jim Hutchinson, David M. Patrick, Karl Weiss, John Conly1
All provinces requiring form submission requested prescriber and patient identification information, the drug requested, and a justification for the request.
2Time to review is the goal for the province, unless otherwise reported.
Summary of provincial drug plan restrictions, criteria for reimbursement, and the lag time from Common Drug Review approval to provincial decision in Canadian provinces.
History
Usage metrics
Categories
Keywords
antimicrobial formulariescorrelations.ConclusionsAlthough antimicrobial formulary listingsyear period.MethodsProvincial drug plan formulariesantimicrobial formulary structurebenefitProvincial Drug Formulary Antimicrobial ListingsCanada Influence Prescribing RatesSpearman rank correlation coefficients.ResultsFormulariesCanadian Integrated ProgramAntimicrobial Resistance Surveillancemacrolide prescription rates
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC